Strengthening Global Collaboration: DiCE CEO Visits Mexico to Support FUTEJE
In March, DiCE CEO Zorana Maravic visited Mexico as Special Advisor for the GCCA, collaborating closely with FUTEJE to enhance colorectal cancer pa...
Turning Potential into Action: How Biosimilars Can Reshape Access and Outcomes in Cancer Care
At BIOS25 in Amsterdam, DiCE highlighted patient perspectives on biosimilars. CEO Zorana Maravic underscored the urgent need to overcome barriers, ...
DiCE Collaborates with GCCA and FUTEJE Towards Improving CRC in Mexico
At DiCE, our commitment to supporting patients affected by Colorectal Cancer knows no boundaries. That’s why we are thrilled to share our rec...